Open company graph database — free web & API
Login

Astellas Pharma Ltd.

アステラス製薬株式会社Alias
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
4
§01

Basic information

BASIC
Head office
東京
Chief executive
岡村直樹
Capital
15,000,000,000 JPY (150 100 millionJPY)
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

5
Rx+事業創成製品疾患領域Access HealthcarePipeline
§04

Related companies

4 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Takeda Teba Pharmaceutical Co., Ltd.
Group
Avara Norman Pharmaceutical Services, Inc.
Group
Nippon Medical & Pharmaceutical Co., Ltd.
Group
Takeda Pharmaceutical Company, Limited
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

7 EVENTS

Yakult Honsha was renamed to Yakult Honsha Co., Ltd. in 1940Sources

In 1942, the headquarters was relocated to TokyoSources

Leaders from Yamanouchi and Fujisawa shake hands, marking the 2005 merger that formed Astellas and shaped a patient-first global strategy.Sources

Leaders of Yakult Honsha and Fujisawa Pharmaceutical exchanged handshakes to commemorate the merger in 2005. This merger led to the founding of Astellas, which developed a global strategy centered on patients. Astellas was established through the merger of Yakult Honsha, founded in 1923, and Fujisawa Pharmaceutical, founded in 1894, in April 2005.Sources

Astellas was established in April 2005 through the merger of two companies – Yamanouchi Pharmaceutical (founded in 1923) and Fujisawa Pharmaceutical (founded in 1894).Sources

Astellas Pharma celebrated its 20th anniversary in April 2025.Sources

In April 2025, Astellas celebrated our 20th Anniversary as a company.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑